NEXT Oncology Enrolls First Patient in Madrid Phase I Clinical Research Center

When NEXT Oncology expanded to Spain in late 2021, the goal was to increase global access to new cancer agents and anticancer therapies for patients with advanced cancer. NEXT Oncology – Madrid has enrolled its first patient in March 2022 in an early phase clinical trial focused on metastatic triple negative breast cancer (TNBC) with an anti-drug conjugate used in monotherapy or in combination with antiPDL1.

Read the full article at Let Life Happen.